TY - JOUR
T1 - Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis
AU - Ticehurst, John R.
AU - Hamzeh, Fayez M.
AU - Thomas, David L.
PY - 2007/8
Y1 - 2007/8
N2 - The serum concentration of hepatitis C virus (HCV) RNA is usually stable (4 to 8 log10 IU/ml) in untreated patients with chronic hepatitis C. While this baseline HCV RNA concentration ([HCV RNA]BL) is predictive of a sustained virologic response to treatment, its determinants are only partially identified. We therefore analyzed the baseline characteristics of 2,472 HCV genotype 1-infected patients to identify correlations with gender, age, race, weight, body mass index (BMI), HCV acquisition mode, HCV subtype, alanine aminotrans-ferase concentration, or histopathologic changes in the liver. After separation of the data according to four [HCV RNA]BL groups (≤5.0, >5.0 to 5.6, >5.6 to 5.9, and >5.9 log10 IU/ml), we determined that increasing [HCV RNA]BL correlated (P < 0.05) with increasing proportions of patients who were male, >40 years of age, or heavier (a weight of >85 kg or a BMI of >27 kg/m2). Histologic activity index (HAI) data were available for 1,304 of these patients: increasing [HCV RNA]BL correlated with higher fibrosis and necrosis-inflammation scores. As a continuous variable, [HCV RNA]BL correlated with age, gender, weight (continuous or ≤85 versus >85 kg), BMI (continuous or ≤27 versus >27 kg/m2), subtype, fibrosis score, and necrosis-inflammation score; however, multiple-regression analysis yielded P values of <0.1 only for age, gender, BMI (≤27 versus >27 kg/m 2), and fibrosis score. While our findings are suggestive of a role for these factors in maintenance of the pretreatment state of HCV infection, the multiple-regression model accounted for only ≤4.6% of the [HCV RNA] BL differences between individuals (R2 = 0.046 for 1,304 patients with HAI scores; 0.043 for all 2,472 patients).
AB - The serum concentration of hepatitis C virus (HCV) RNA is usually stable (4 to 8 log10 IU/ml) in untreated patients with chronic hepatitis C. While this baseline HCV RNA concentration ([HCV RNA]BL) is predictive of a sustained virologic response to treatment, its determinants are only partially identified. We therefore analyzed the baseline characteristics of 2,472 HCV genotype 1-infected patients to identify correlations with gender, age, race, weight, body mass index (BMI), HCV acquisition mode, HCV subtype, alanine aminotrans-ferase concentration, or histopathologic changes in the liver. After separation of the data according to four [HCV RNA]BL groups (≤5.0, >5.0 to 5.6, >5.6 to 5.9, and >5.9 log10 IU/ml), we determined that increasing [HCV RNA]BL correlated (P < 0.05) with increasing proportions of patients who were male, >40 years of age, or heavier (a weight of >85 kg or a BMI of >27 kg/m2). Histologic activity index (HAI) data were available for 1,304 of these patients: increasing [HCV RNA]BL correlated with higher fibrosis and necrosis-inflammation scores. As a continuous variable, [HCV RNA]BL correlated with age, gender, weight (continuous or ≤85 versus >85 kg), BMI (continuous or ≤27 versus >27 kg/m2), subtype, fibrosis score, and necrosis-inflammation score; however, multiple-regression analysis yielded P values of <0.1 only for age, gender, BMI (≤27 versus >27 kg/m 2), and fibrosis score. While our findings are suggestive of a role for these factors in maintenance of the pretreatment state of HCV infection, the multiple-regression model accounted for only ≤4.6% of the [HCV RNA] BL differences between individuals (R2 = 0.046 for 1,304 patients with HAI scores; 0.043 for all 2,472 patients).
UR - http://www.scopus.com/inward/record.url?scp=34548081220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548081220&partnerID=8YFLogxK
U2 - 10.1128/JCM.02448-06
DO - 10.1128/JCM.02448-06
M3 - Article
C2 - 17537941
AN - SCOPUS:34548081220
SN - 0095-1137
VL - 45
SP - 2426
EP - 2433
JO - Journal of clinical microbiology
JF - Journal of clinical microbiology
IS - 8
ER -